GetTopicDetailResponse(id=a16768316c5, topicName=王曉東, introduction=王曉東, content=null, image=null, comments=1, allHits=1849, url=https://h5.medsci.cn/topic?id=68316, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=17328, tagList=[TagDto(tagId=17328, tagName=王曉東)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=897028, encodeId=fb7f89e02822, content=<a href='/topic/show?id=4a76919411b' target=_blank style='color:#2F92EE;'>#諾誠健華#</a>是著名科學家<a href='/topic/show?id=bf6758e90bf' target=_blank style='color:#2F92EE;'>#施一公#</a>創(chuàng)立，同期的美國科學院院士<a href='/topic/show?id=a16768316c5' target=_blank style='color:#2F92EE;'>#王曉東#</a>創(chuàng)立了<a href='/topic/show?id=ac55e188816' target=_blank style='color:#2F92EE;'>#百濟神州#</a>，可惜<a href='/topic/show?id=4187101280e9' target=_blank style='color:#2F92EE;'>#饒毅#</a>沒有創(chuàng)立公司。現在百濟已經是巨頭，諾城健華上升很快，<a href='/topic/show?id=f67910401150' target=_blank style='color:#2F92EE;'>#奧布替尼#</a>很厲害！, objectTitle=諾誠健華奧布替尼獲美國FDA批準開展治療多發(fā)性硬化癥臨床II期研究, objectType=article, longId=202938, objectId=6e7f20293886, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20201019/143455a04a6645338612b98e5e30a5e1.jpg, objectUrl=/article/show_article.do?id=6e7f20293886, replyNumber=0, likeNumber=227, createdTime=2020-11-05, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e7f20293886, moduleTitle=諾誠健華奧布替尼獲美國FDA批準開展治療多發(fā)性硬化癥臨床II期研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6e7f20293886)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
